Vaccinex Financials

Vaccinex Stock Summary

Vaccinex competes with Protara Therapeutics, Monopar Therapeutics, Surrozen, Salarius Pharmaceuticals, and SAB Biotherapeutics. Vaccinex, Inc., a clinical-stage biotechnology company, focuses on treating cancer and neurodegenerative disease through the inhibition of semaphorin 4D . Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York. Vaccinex operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.

Vaccinex Key Financial Ratios

Vaccinex Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Vaccinex's current stock value. Our valuation model uses many indicators to compare Vaccinex value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vaccinex competition to find correlations between indicators driving Vaccinex's intrinsic value. More Info.Vaccinex is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vaccinex's earnings, one of the primary drivers of an investment's value.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stocks Directory module to find actively traded stocks across global markets.

If you are still planning to invest in Vaccinex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccinex's history and understand the potential risks before investing.